TFCM
NVCR icon

Taylor Frigon Capital Management’s NovoCure NVCR Stock Holding History

Taylor Frigon Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-120,231
Closed -$2.14M – 93
2025
Q2 		$2.14M Sell
120,231
-7,317
-6% -$128K 1.14% 42
2025
Q1 		$2.27M Sell
127,548
-15,894
-11% -$361K 1.35% 17
2024
Q4 		$4.27M Sell
143,442
-16,604
-10% -$351K 2.16% 3
2024
Q3 		$2.5M Buy
160,046
+26,748
+20% +$485K 1.25% 29
2024
Q2 		$2.28M Buy
133,298
+6,384
+5% +$112K 1.09% 37
2024
Q1 		$1.98M Buy
126,914
+30,057
+31% +$442K 0.95% 45
2023
Q4 		$1.45M Buy
96,857
+5,422
+6% +$72.6K 0.73% 59
2023
Q3 		$1.48M Buy
91,435
+24,790
+37% +$715K 0.82% 52
2023
Q2 		$2.77M Buy
66,645
+25,244
+61% +$1.57M 1.35% 28
2023
Q1 		$2.49M Sell
41,401
-660
-2% -$52.7K 1.36% 26
2022
Q4 		$3.09M Sell
42,061
-2,857
-6% -$215K 1.75% 16
2022
Q3 		$3.41M Sell
44,918
-23,990
-35% -$1.87M 1.78% 12
2022
Q2 		$4.79M Sell
68,908
-4,106
-6% -$309K 2.49% 6
2022
Q1 		$6.05M Buy
73,014
+26,638
+57% +$1.96M 2.25% 9
2021
Q4 		$3.48M Buy
46,376
+528
+1% +$53K 1.09% 36
2021
Q3 		$5.33M Buy
45,848
+14,813
+48% +$2.24M 1.72% 22
2021
Q2 		$6.88M Sell
31,035
-17,614
-36% -$3.43M 2.15% 6
2021
Q1 		$6.43M Sell
48,649
-341
-0.7% -$53.9K 1.98% 14
2020
Q4 		$8.48M Buy
48,990
+2,094
+4% +$287K 2.78% 4
2020
Q3 		$5.22M Buy
46,896
+592
+1% +$47.3K 2.3% 5
2020
Q2 		$2.75M Buy
46,304
+3,402
+8% +$224K 1.36% 30
2020
Q1 		$2.89M Buy
42,902
+4,829
+13% +$382K 2.26% 7
2019
Q4 		$3.21M Sell
38,073
-3,125
-8% -$252K 2.21% 4
2019
Q3 		$3.08M Sell
41,198
-5,401
-12% -$432K 2.23% 4
2019
Q2 		$2.95M Buy
46,599
+4,110
+10% +$208K 2.04% 8
2019
Q1 		$2.05M Sell
42,489
-1,197
-3% -$57.6K 1.59% 20
2018
Q4 		$1.46M Buy
+43,686
New +$1.6M 1.29% 37

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Taylor Frigon Capital Management's NVCR Position: Q3 2025 in Review

Taylor Frigon Capital Management sold out of NovoCure (NVCR) in Q3 2025, closing a stake of 120,231 shares — an estimated $2.14M sold.

Taylor Frigon Capital Management first reported a position in NVCR in Q4 2018 and held it in 27 quarters. The position peaked at $8.48M in Q4 2020. 245 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Taylor Frigon Capital Management reported no remaining NovoCure position as of Q3 2025 after selling out during the quarter.
  • Taylor Frigon Capital Management sold 120,231 NovoCure shares in Q3 2025, an estimated $2.14M.
  • Taylor Frigon Capital Management first reported a position in NovoCure in Q4 2018 and held it in 27 quarters.
  • Taylor Frigon Capital Management's NovoCure position peaked at $8.48M in Q4 2020.
  • 245 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Taylor Frigon Capital Management's 13F filing for Q3 2025, filed 21 Oct 2025.